Cullinan Oncology Inc
NASDAQ:CGEM
Cash Flow Statement
Cash Flow Statement
Cullinan Oncology Inc
Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||||||
Net Income |
(31)
|
(35)
|
(59)
|
(58)
|
(55)
|
(62)
|
(67)
|
(82)
|
109
|
102
|
109
|
64
|
(142)
|
(157)
|
(155)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(20)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Stock-Based Compensation |
0
|
0
|
15
|
18
|
23
|
27
|
24
|
27
|
32
|
33
|
28
|
29
|
28
|
30
|
0
|
|
Other Non-Cash Items |
7
|
8
|
23
|
27
|
25
|
29
|
28
|
31
|
(241)
|
(241)
|
(247)
|
(249)
|
24
|
24
|
21
|
|
Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
38
|
0
|
5
|
5
|
4
|
|
Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Change in Working Capital |
2
|
2
|
7
|
0
|
(6)
|
(5)
|
(4)
|
6
|
59
|
22
|
11
|
9
|
(43)
|
(9)
|
(0)
|
|
Cash from Operating Activities |
(22)
N/A
|
(25)
-15%
|
(30)
-18%
|
(31)
-5%
|
(36)
-16%
|
(38)
-4%
|
(43)
-15%
|
(64)
-47%
|
(73)
-14%
|
(117)
-60%
|
(127)
-8%
|
(156)
-23%
|
(161)
-4%
|
(141)
+13%
|
(134)
+5%
|
|
Investing Cash Flow | ||||||||||||||||
Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
Other Items |
(50)
|
(52)
|
(5)
|
(143)
|
(283)
|
(306)
|
(334)
|
(161)
|
294
|
262
|
250
|
231
|
(58)
|
(43)
|
36
|
|
Cash from Investing Activities |
(50)
N/A
|
(52)
-4%
|
(5)
+90%
|
(143)
-2 541%
|
(283)
-98%
|
(306)
-8%
|
(334)
-9%
|
(161)
+52%
|
294
N/A
|
262
-11%
|
249
-5%
|
229
-8%
|
(59)
N/A
|
(44)
+25%
|
36
N/A
|
|
Financing Cash Flow | ||||||||||||||||
Net Issuance of Common Stock |
99
|
99
|
139
|
406
|
392
|
393
|
271
|
5
|
8
|
9
|
6
|
4
|
40
|
39
|
39
|
|
Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
|
Other |
(1)
|
1
|
1
|
(2)
|
(1)
|
(2)
|
(2)
|
2
|
1
|
1
|
(32)
|
(33)
|
(33)
|
(33)
|
0
|
|
Cash from Financing Activities |
98
N/A
|
99
+1%
|
140
+41%
|
405
+189%
|
392
-3%
|
391
0%
|
269
-31%
|
8
-97%
|
9
+14%
|
10
+10%
|
(26)
N/A
|
(28)
-7%
|
9
N/A
|
8
-15%
|
41
+437%
|
|
Change in Cash | ||||||||||||||||
Net Change in Cash |
26
N/A
|
22
-15%
|
105
+383%
|
230
+119%
|
73
-68%
|
47
-35%
|
(108)
N/A
|
(217)
-101%
|
230
N/A
|
155
-33%
|
96
-38%
|
46
-52%
|
(212)
N/A
|
(178)
+16%
|
(58)
+68%
|
|
Free Cash Flow | ||||||||||||||||
Free Cash Flow |
(22)
N/A
|
(25)
-14%
|
(30)
-18%
|
(31)
-5%
|
(36)
-16%
|
(38)
-4%
|
(43)
-15%
|
(64)
-47%
|
(73)
-14%
|
(117)
-60%
|
(128)
-9%
|
(157)
-23%
|
(163)
-4%
|
(142)
+13%
|
(134)
+5%
|